Fetuin-A: A novel link between obesity and related complications

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · see citing works

Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia

Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541 · see citing works

Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

Blacher, J., Guérin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2001) · Hypertension · doi:10.1161/hy1001.096358 · Cited by 1,416 · see citing works

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · see citing works

The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

Schäfer, C., Heiss, A., Schwarz, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 919 · see citing works

Insulin-sensitive obesity

Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M. R., Kern, M., Stumvoll, M., & Blüher, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2009 · Cited by 856 · see citing works

Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24

Vionnet, N., Hani, E. H., Dupont, S., Gallina, S., Francke, S., Dotte, S., de Matos, F., Durand, E., Leprêtre, F., Lecœur, C., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316887 · Cited by 679 · see citing works

The role of hepatokines in metabolism

Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · see citing works

α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans

Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F. E., Fritsche, A., & Häring, H. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1938 · Cited by 475 · see citing works

Plasma fetuin-A levels and the risk of type 2 diabetes

Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379 · see citing works

Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg Gene

Mathews, S. T., Singh, G. P., Ranalletta, M., Cintrón, V. J., Qiang, X., Goustin, A. S., Jen, K. C., Charron, M. J., Jahnen‐Dechent, W., & Grunberger, G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2450 · Cited by 343 · see citing works

Nanoparticle-Based Test Measures Overall Propensity for Calcification in Serum

Pasch, A., Farese, S., Gräber, S., Wald, J., Richtering, W. H., Floege, J., & Jahnen‐Dechent, W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030240 · Cited by 341 · see citing works

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

Auberger, P., Falquerho, L., Contreres, J. O., Pagès, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321 · see citing works

Association Between Human Fetuin-A and the Metabolic Syndrome

Ix, J. H., Shlipak, M. G., Brandenburg, V. M., Ali, S., Ketteler, M., & Whooley, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.588723 · Cited by 316 · see citing works

Fetuin, a New Globulin Isolated from Serum

Pedersen, K. O. (1944) · Nature · doi:10.1038/154575a0 · Cited by 289 · see citing works

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282 · see citing works

Preparation and Properties of Zn-α2-glycoprotein of Normal Human Plasma

Bürgi, W., & Schmid, K. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64243-7 · Cited by 272 · see citing works

Fetuin-A and Incident Diabetes Mellitus in Older Persons

Ix, J. H. (2008) · JAMA · doi:10.1001/jama.300.2.182 · Cited by 267 · see citing works

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

Færch, K., Borch‐Johnsen, K., Holst, J. J., & Vaag, A. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1443-3 · Cited by 255 · see citing works

Serum Calcification Propensity Predicts All-Cause Mortality in Predialysis CKD

Smith, E. R., Ford, M. L., Tomlinson, L. A., Bodenham, E., McMahon, L. P., Farese, S., Rajkumar, C., Holt, S. G., & Pasch, A. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060635 · Cited by 247 · see citing works

Vascular calcification: from pathophysiology to biomarkers

Evrard, S., Delanaye, P., Kamel, S., Cristol, J., Cavalier, E., Arnaud, J., Zaoui, P., Carlier, M.-C., Laville, M., Fouque, D. P., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.034 · Cited by 244 · see citing works

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level

Srinivas, P. R., Wagner, A. S., Reddy, L. V. K., Deutsch, D. D., Leon, M. A., Goustin, A. S., & Grunberger, G. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.7906861 · Cited by 243 · see citing works

Fetuin-Mineral Complex Reflects Extraosseous Calcification Stress in CKD

Hamano, T., Matsui, I., Mikami, S., Tomida, K., Fujii, N., Imai, E., Rakugi, H., & Isaka, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090944 · Cited by 223 · see citing works

Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD

Smith, E. R., Ford, M. L., Tomlinson, L. A., Rajkumar, C., McMahon, L. P., & Holt, S. G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr609 · Cited by 215 · see citing works

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

Reinehr, T., & Roth, C. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1505 · Cited by 209 · see citing works

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

Haukeland, J. W., Dahl, T. B., Yndestad, A., Gladhaug, I. P., Løberg, E. M., Haaland, T., Konopski, Z., Wium, C., Aasheim, E. T., Johansen, O. E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0864 · Cited by 186 · see citing works

NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance

Dasgupta, S., Bhattacharya, S., Biswas, A., Majumdar, S. S., Mukhopadhyay, S., Ray, S., & Bhattacharya, S. (2010) · Biochemical Journal · doi:10.1042/bj20100330 · Cited by 168 · see citing works

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

Stefan, N., & Häring, H.-U. (2013) · Nature Medicine · doi:10.1038/nm.3116 · Cited by 160 · see citing works

Serum fetuin-A in nondialyzed patients with diabetic nephropathy: Relationship with coronary artery calcification

Mehrotra, R., Westenfeld, R., Christenson, P., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00172.x · Cited by 155 · see citing works

Fetuin-B, a second member of the fetuin family in mammals

Olivier, E. N., Soury, E., Ruminy, P., Husson, A., Parmentier, F., Daveau, M., & Salier, J. (2000) · Biochemical Journal · doi:10.1042/bj3500589 · Cited by 154 · see citing works

Effects of a three‐month combined exercise programme on fibroblast growth factor 21 and fetuin‐A levels and arterial stiffness in obese women

Yang, S. J., Hong, H. C., Choi, H. Y., Yoo, H. J., Cho, G. J., Hwang, T. G., Baik, S. H., Choi, D. S., Kim, S. M., & Choi, K. M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04078.x · Cited by 148 · see citing works

Two Patterns of Adipokine and Other Biomarker Dynamics in a Long-Term Weight Loss Intervention

Blüher, M., Rudich, A., Klöting, N., Golan, R., Henkin, Y., Rubin, E., Schwarzfuchs, D., Gepner, Y., Stampfer, M. J., Fiedler, M., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1267 · Cited by 135 · see citing works

The nucleotide and partial amino acid sequences of rat fetuin

Rauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 134 · see citing works

Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages

Chatterjee, P., Seal, S., Mukherjee, S., Kundu, R., Mukherjee, S., Ray, S., Mukhopadhyay, S., Majumdar, S. S., & Bhattacharya, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.495473 · Cited by 132 · see citing works

Fetuin-null mice are protected against obesity and insulin resistance associated with aging

Mathews, S. T., Rakhade, S. N., Zhou, X., Parker, G. C., Coscina, D. V., & Grunberger, G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.071 · Cited by 129 · see citing works

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

Brix, J. M., Stingl, H., Höllerl, F., Schernthaner, G.-H., Kopp, H.-P., & Schernthaner, G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0148 · Cited by 112 · see citing works

Deoxyribonucleotides as genetic and metabolic regulators

Mathews, C. K. (2014) · The FASEB Journal · doi:10.1096/fj.14-251249 · Cited by 95 · see citing works

Plasma fetuin‐ A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease

Doğru, T., Genç, H., Tapan, S., Aslan, F., Erçin, C. N., Örs, F., Kara, M., Sertoğlu, E., Karslıoğlu, Y., Bağcı, S., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04460.x · Cited by 90 · see citing works

The Association of Fetuin-A With Cardiovascular Disease Mortality in Older Community-Dwelling Adults

Laughlin, G. A., Cummins, K. M., Wassel, C. L., Daniels, L. B., & Ix, J. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.038 · Cited by 88 · see citing works

Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults

Jensen, M. K., Bartz, T. M., Mukamal, K. J., Djoussé, L., Kizer, J. R., Tracy, R. P., Zieman, S. J., Rimm, E. B., Siscovick, D. S., Shlipak, M. G., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1591 · Cited by 88 · see citing works

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.

Sun, Q., Cornelis, M. C., Manson, J. E., & Hu, F. B. (2012) · Diabetes · doi:10.2337/db12-0372 · Cited by 87 · see citing works

Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity

Malin, S. K., del Rincon, J. P., Huang, H., & Kirwan, J. P. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000338 · Cited by 85 · see citing works

Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A

Jung, T. W., Youn, B., Choi, H. Y., Lee, S. Y., Hong, H. C., Yang, S. J., Yoo, H. J., Kim, B., Baik, S. H., & Choi, K. M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.034 · Cited by 82 · see citing works

Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes

Kalabay, L., Cseh, K., Pajor, A., et al. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470243 · Cited by 81 · see citing works

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

Stefan, N., Sun, Q., Fritsche, A., Machann, J., Schick, F., Gerst, F., Jeppesen, C., Joost, H., Hu, F. B., Boeing, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092238 · Cited by 80 · see citing works

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity

Lin, X., Braymer, H. D., Bray, G. A., & York, D. A. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00250-1 · Cited by 79 · see citing works

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

Mori, K., Emoto, M., Araki, T., Yokoyama, H., Lee, E., Teramura, M., Koyama, H., Shoji, T., Inaba, M., & Nishizawà, Y. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.019 · Cited by 77 · see citing works

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

Xu, Y., Xu, M., Bi, Y., Song, A., Huang, Y., Liu, Y., Wu, Y., Chen, Y., Wang, W., Li, X., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.020 · Cited by 76 · see citing works

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

Lorant, D., Grujicic, M., Höbaus, C., Brix, J., Höllerl, F., Schernthaner, G., Koppensteiner, R., & Schernthaner, G.-H. (2010) · Diabetes Care · doi:10.2337/dc10-0788 · Cited by 76 · see citing works

A Synonymous Coding Polymorphism in the α2-Heremans-Schmid Glycoprotein Gene Is Associated With Type 2 Diabetes in French Caucasians

Siddiq, A., Leprêtre, F., Herçberg, S., Froguel, P., & Gibson, F. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2477 · Cited by 75 · see citing works

Fetuin‐A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

Sato, M., Kamada, Y., Takeda, Y., Kida, S., Ohara, Y., Fujii, H., Akita, M., Mizutani, K., Yoshida, Y., Yamada, M., et al. (2014) · Liver International · doi:10.1111/liv.12478 · Cited by 72 · see citing works

Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults

Ix, J. H., Biggs, M. L., Mukamal, K. J., Kizer, J. R., Zieman, S. J., Siscovick, D. S., Mozaffarian, D., Jensen, M. K., Nelson, L., Ruderman, N. B., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.072751 · Cited by 71 · see citing works

Increased Fetuin-A Concentrations in Impaired Glucose Tolerance with or without Nonalcoholic Fatty Liver Disease, But Not Impaired Fasting Glucose

Ou, H., Yang, Y., Wu, H., Wu, J., Lu, F., & Chang, C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2414 · Cited by 69 · see citing works

Endoplasmic Reticulum Stress Induces the Expression of Fetuin-A to Develop Insulin Resistance

Ou, H., Wu, H., Hung, H., Yang, Y., Wu, J., & Chang, C. (2012) · Endocrinology · doi:10.1210/en.2011-2043 · Cited by 69 · see citing works

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease

Malin, S. K., Mulya, A., Fealy, C. E., Haus, J. M., Pagadala, M. R., Scelsi, A. R., Huang, H., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00237.2013 · Cited by 68 · see citing works

Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase

Mathews, S. T., Srinivas, P. R., Leon, M. A., & Grunberger, G. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00737-6 · Cited by 68 · see citing works

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction

Yin, J., Peng, Y., Wu, J., Wang, Y., & Yao, L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313143 · Cited by 67 · see citing works

High Glucose Induces Transactivation of the .ALPHA.2-HS Glycoprotein Gene Through the ERK1/2 Signaling Pathway

Takata, H., Ikeda, Y., Suehiro, T., Ishibashi, A., Inoue, M., Kumon, Y., & Terada, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no950 · Cited by 66 · see citing works

Serum fetuin A/ α 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

Yilmaz, Y. N., Yönal, O., Kurt, R., Arı, F., Oral, A. Y., Çelikel, Ç., KORKMAZ, Ş., Ulukaya, E., Ozdogan, O. C., İmeryüz, N., et al. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010169 · Cited by 64 · see citing works

?2-Heremans?Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action

Dahlman, I. A., Eriksson, P. O., Kaaman, M., Jiao, H., Lindgren, C. M., Kere, J., & Arner, P. (2004) · Diabetologia · doi:10.1007/s00125-004-1556-7 · Cited by 63 · see citing works

The effects of caloric restriction on F etuin‐ A and cardiovascular risk factors in rats and humans: a randomized controlled trial

Choi, K. M., Han, K. A., Ahn, H. J., Lee, S. Y., Hwang, S. Y., Kim, B. C., Hong, H. C., Choi, H. Y., Yang, S. J., Yoo, H. J., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12076 · Cited by 60 · see citing works

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes

Eraso, L. H., Ginwala, N., Qasim, A., Mehta, N. N., Dlugash, R., Kapoor, S. C., Schwartz, S. J., Schutta, M. H., Iqbal, N., Mohler, E. R., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1541 · Cited by 58 · see citing works

Charakterisierung eines niedermolekularen ?2-Mukoids aus Humanserum

Schultze, H. E., Heide, K., & HAUPT, H. (1962) · Die Naturwissenschaften · doi:10.1007/bf00632835 · Cited by 56 · see citing works

AHSG gene variant is associated with leanness among Swedish men

Lavebratt, C., Wahlqvist, S., Nordfors, L., Hoffstedt, J., & Arner, P. (2005) · Human Genetics · doi:10.1007/s00439-005-1286-z · Cited by 54 · see citing works

Sex-Specific Association of Fetuin-A With Type 2 Diabetes in Older Community-Dwelling Adults

Laughlin, G. A., Barrett-Connor, E. L., Cummins, K. M., Daniels, L. B., Wassel, C. L., & Ix, J. H. (2013) · Diabetes Care · doi:10.2337/dc12-1870 · Cited by 51 · see citing works

Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor

Goustin, A. S., Derar, N., & Abou-Samra, A. B. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.011 · Cited by 51 · see citing works

AHSG Tag Single Nucleotide Polymorphisms Associate With Type 2 Diabetes and Dyslipidemia

Andersen, G., Burgdorf, K. S., Sparsø, T., Borch‐Johnsen, K., Jørgensen, T., Hansen, T. F., & Pedersen, O. B. (2008) · Diabetes · doi:10.2337/db07-0558 · Cited by 51 · see citing works

Fetuin-A and change in body composition in older persons

Ix, J. H., Wassel, C. L., Chertow, G. M., Koster, A., Johnson, K. C., Tylavsky, F. A., Cauley, J. A., Cummings, S. R., Harris, T. B., Shlipak, M. G., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0916 · Cited by 51 · see citing works

Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes

Jüllig, M., Yip, S., Xu, A., Smith, G., Middleditch, M., Booth, M., Babor, R., Beban, G. R., & Murphy, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096489 · Cited by 50 · see citing works

Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction

Vörös, K., Gráf, L., Prohászka, Z., Gráf, L., Szenthe, P., Kaszás, E., Böröcz, Z., Cseh, K., & Kalabay, L. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02456.x · Cited by 48 · see citing works

Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients

Chen, H., Chiu, Y.-L., Hsu, S., Pai, M., Lai, C., Peng, Y., Kao, T., Hung, K., Tsai, T., & Wu, K. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0813 · Cited by 47 · see citing works

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats

Matsui, I., Hamano, T., Mikami, S., et al. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00329.2012 · Cited by 42 · see citing works

Genetically Elevated Fetuin-A Levels, Fasting Glucose Levels, and Risk of Type 2 Diabetes

Jensen, M. K., Bartz, T. M., Djoussé, L., Kizer, J. R., Zieman, S. J., Rimm, E. B., Siscovick, D. S., Psaty, B. M., Ix, J. H., & Mukamal, K. J. (2013) · Diabetes Care · doi:10.2337/dc12-2323 · Cited by 41 · see citing works

Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus

Rasul, S., Wagner, L., & Kautzky‐Willer, A. (2012) · Endocrine · doi:10.1007/s12020-012-9754-4 · Cited by 36 · see citing works

Secretion of a major phosphorylated glycoprotein by hepatocytes. Characterization of specific antibodies and investigations of the processing, excretion kinetics, and phosphorylation.

Cam, A. L., Magnaldo, I., Cam, G. L., et al. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36353-6 · Cited by 33 · see citing works

A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle

Hussey, S. E., Lum, H., Alvarez, A. V., Cipriani, Y., Garduño‐García, J. D. J., Anaya, L., Dubé, J. J., & Musi, N. (2013) · Diabetologia · doi:10.1007/s00125-013-3111-x · Cited by 31 · see citing works

Polymorphism of the AHSG gene is associated with increased adipocyte β2-adrenoceptor function

Lavebratt, C., Dungner, E., & Hoffstedt, J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500201-jlr200 · Cited by 29 · see citing works

α2-Heremans Schmid Glycoprotein Inhibits Insulin-Stimulated Elk-1 Phosphorylation, But Not Glucose Transport, in Rat Adipose Cells**This work was supported in part by a Research Award grant from the American Diabetes Association (to M.J.Q.).

Chen, H., Srinivas, P. R., Cong, L.-N., Li, Y., Grunberger, G., & Quon, M. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6258 · Cited by 26 · see citing works

Hepatic steatosis and PNPLA 3 I148 M variant are associated with serum F etuin‐ A independently of insulin resistance

Rametta, R., Ruscica, M., Dongiovanni, P., Macchi, C., Fracanzani, A. L., Steffani, L., Fargion, S. R., Magni, P., & Valenti, L. V. C. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12280 · Cited by 25 · see citing works

Causal relationship between body mass index and fetuin‐ A level in the asian population: a bidirectional mendelian randomization study

Thakkinstian, A., Chailurkit, L., Warodomwichit, D., Ratanachaiwong, W., Yamwong, S., Chanprasertyothin, S., Attia, J., Sritara, P., & Ongphiphadhanakul, B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12303 · Cited by 25 · see citing works

The Effect of 6-Weeks of Aerobic Exercise Training on Serum Fetuin-A levels in Non-Diabetic Obese Women

Schultes, B., Frick, J. E., Ernst, B., Stefan, N., & Fritsche, A. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1253418 · Cited by 23 · see citing works

AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?

Xu, X. J., Valentine, R. J., & Ruderman, N. B. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0095-x · Cited by 22 · see citing works

Recombinant human α2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster Ovary cells overexpressing the human insulin receptor

Srinivas, P. R., Deutsch, D. D., Mathews, S. T., Goustin, A. S., Leon, M. A., & Grunberger, G. (1996) · Cellular Signalling · doi:10.1016/s0898-6568(96)00110-6 · Cited by 22 · see citing works

Raised Circulating Fetuin-A After 28-Day Overfeeding in Healthy Humans

Samocha‐Bonet, D., Tam, C. S., Campbell, L. V., & Heilbronn, L. K. (2013) · Diabetes Care · doi:10.2337/dc13-1728 · Cited by 19 · see citing works

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes

Stefan, N., Weikert, C., Ix, J. H., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0002 · Cited by 8 · see citing works

Plasma fetuin‐A and phosphofetuin‐A (Ser312) responses to a single or short‐term repeated bout of exercise in obese and normal‐weight individuals (1028.2)

Mathews, S. T., Ren, G., He, X., Bowers, R. L., Araya-Ramírez, F., Littlefield, L. A., & Grandjean, P. W. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.1028.2 · Cited by 7 · see citing works

695 Fetuin-a Binding to TLR4 Regulates NASH and Fibrosis: The Role of TRIF

Yang, L., Zhang, B., Song, J., et al. (2014) · Gastroenterology · doi:10.1016/s0016-5085(14)63351-5 · Cited by 1 · see citing works

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review

Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works

Causal relationship between diet-induced gut microbiota changes and diabetes: a novel strategy to transplant Faecalibacterium prausnitzii in preventing diabetes

Ganesan, K., Chung, S. K., Vanamala, J., & Xu, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123720 · Cited by 221 · see citing works

Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial

Ezpeleta, M., Gabel, K., Cienfuegos, S., Kalam, F., Lin, S., Pavlou, V., Song, Z., Haus, J. M., Koppe, S., Alexandria, S. J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.001 · Cited by 181 · see citing works

Implication of hepatokines in metabolic disorders and cardiovascular diseases

Jung, T. W., Yoo, H. J., & Choi, K. M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.03.002 · Cited by 71 · see citing works

The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men

Sargeant, J. A., Aithal, G. P., Takamura, T., Misu, H., Takayama, H., Douglas, J. A., Turner, M. C., Stensel, D. J., Nimmo, M. A., Webb, D. R., et al. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0639 · Cited by 56 · see citing works

Role of exercise-induced hepatokines in metabolic disorders

Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54 · see citing works

Organokines in disease

(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46 · see citing works

Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: A systematic review and Meta-analysis

Ramírez-Vélez, R., García-Hermoso, A., Hackney, A. C., & Izquierdo, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0962-2 · Cited by 37 · see citing works

Acute hyperenergetic, high-fat feeding increases circulating FGF21, LECT2, and fetuin-A in healthy men

Willis, S. A., Sargeant, J. A., Yates, T., Takamura, T., Takayama, H., Gupta, V., Brittain, E., Crawford, J., Parry, S. A., Thackray, A. E., et al. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz333 · Cited by 34 · see citing works

Contribution of Liver Fat to Weight Loss–Induced Changes in Serum Hepatokines: A Randomized Controlled Trial

Telgenkamp, I., Kusters, Y. H. A. M., Schalkwijk, C. G., Houben, A. J. H. M., Kooi, M. E., Lindeboom, L., Bons, J. A. P., Schaper, N. C., Joris, P. J., Plat, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02378 · Cited by 18 · see citing works

Fetuin-a expression profile in mouse and human adipose tissue

Khadir, A., Kavalakatt, S., Madhu, D., & Tiss, A. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01225-7 · Cited by 4 · see citing works

Prevalence of fatty liver in metabolic syndrome

Goyal, A., Arora, H., & Arora, S. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1108_19 · Cited by 17 · see citing works

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

Montecucco, F., & Mach, F. (2008) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153008786848268 · Cited by 17 · see citing works

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Cheng, Y.-L., Wang, Y.-J., Lan, K.-H., Huo, T.-I., Huang, Y.-H., Su, C.-W., Hsieh, W., Hou, M.-C., Lin, H.-C., Lee, F., et al. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/9279836 · Cited by 27 · see citing works

Features of myocardial damage indexes in patients with metabolic syndrome and nonalcoholic fatty liver disease

Собирова, Г. Н., Uzokov, J., Bafoeva, Z. O., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155040 · Cited by 1 · see citing works

Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Vyas, K. Y., & Patel, J. K. (2019) · Indian Practitioner